These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38348128)

  • 1. Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke.
    Fisher ES; Chen Y; Sifuentes MM; Stubblefield JJ; Lozano D; Holstein DM; Ren J; Davenport M; DeRosa N; Chen TP; Nickel G; Liston TE; Lechleiter JD
    Front Stroke; 2022; 1():. PubMed ID: 38348128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain Infarction in a Nonhuman Primate Model of Stroke.
    Liston TE; Hama A; Boltze J; Poe RB; Natsume T; Hayashi I; Takamatsu H; Korinek WS; Lechleiter JD
    Stroke; 2022 Jan; 53(1):238-248. PubMed ID: 34802248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Roles of the Adenosine A
    Bozdemir E; Vigil FA; Chun SH; Espinoza L; Bugay V; Khoury SM; Holstein DM; Stoja A; Lozano D; Tunca C; Sprague SM; Cavazos JE; Brenner R; Liston TE; Shapiro MS; Lechleiter JD
    Neurotherapeutics; 2021 Oct; 18(4):2707-2721. PubMed ID: 34608616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
    Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
    J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.
    Safran N; Shneyvays V; Balas N; Jacobson KA; Nawrath H; Shainberg A
    Mol Cell Biochem; 2001 Jan; 217(1-2):143-52. PubMed ID: 11269659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.
    Mulloy DP; Sharma AK; Fernandez LG; Zhao Y; Lau CL; Kron IL; Laubach VE
    Ann Thorac Surg; 2013 May; 95(5):1762-7. PubMed ID: 23541429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different effects of four adenosine receptors in liver fibrosis.
    Yang L; Gao ZW; Wang X; Wu XN; Li SM; Dong K; Zhu XM
    Front Pharmacol; 2024; 15():1424624. PubMed ID: 39290867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.
    Galvao J; Elvas F; Martins T; Cordeiro MF; Ambrósio AF; Santiago AR
    Exp Eye Res; 2015 Nov; 140():65-74. PubMed ID: 26297614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration.
    Ohsawa K; Sanagi T; Nakamura Y; Suzuki E; Inoue K; Kohsaka S
    J Neurochem; 2012 Apr; 121(2):217-27. PubMed ID: 22335470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective modulation of epileptic tissue by an adenosine A
    Ghosh A; Ribeiro-Rodrigues L; Ruffolo G; Alfano V; Domingos C; Rei N; Tosh DK; Rombo DM; Morais TP; Valente CA; Xapelli S; Bordadágua B; Rainha-Campos A; Bentes C; Aronica E; Diógenes MJ; Vaz SH; Ribeiro JA; Palma E; Jacobson KA; Sebastião AM
    Br J Pharmacol; 2024 Dec; 181(24):5041-5061. PubMed ID: 39300608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats.
    Li P; Li X; Deng P; Wang D; Bai X; Li Y; Luo C; Belguise K; Wang X; Wei X; Xia Z; Yi B
    Aging (Albany NY); 2020 Nov; 13(1):694-713. PubMed ID: 33253120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke.
    Joseph JP; Mecca AP; Regenhardt RW; Bennion DM; Rodríguez V; Desland F; Patel NA; Pioquinto DJ; Unger T; Katovich MJ; Steckelings UM; Sumners C
    Neuropharmacology; 2014 Jun; 81():134-41. PubMed ID: 24508710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents.
    Haeusler D; Kuntner C; Nics L; Savli M; Zeilinger M; Wanek T; Karagiannis P; Lanzenberger RR; Langer O; Shanab K; Spreitzer H; Wadsak W; Hacker M; Mitterhauser M
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):741-9. PubMed ID: 25601336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular implants loaded with A
    Boia R; Dias PAN; Galindo-Romero C; Ferreira H; Aires ID; Vidal-Sanz M; Agudo-Barriuso M; Bernardes R; Santos PF; de Sousa HC; Ambrósio AF; Braga MEM; Santiago AR
    J Control Release; 2022 Mar; 343():469-481. PubMed ID: 35131370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Characterization of Agonist Binding to an A
    Stamatis D; Lagarias P; Barkan K; Vrontaki E; Ladds G; Kolocouris A
    J Med Chem; 2019 Oct; 62(19):8831-8846. PubMed ID: 31502843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Adenosine A
    Ferreira-Silva J; Aires ID; Boia R; Ambrósio AF; Santiago AR
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33007835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhage.
    Luo C; Yi B; Tao G; Li M; Chen Z; Tang W; Zhang JH; Feng H
    Neuroreport; 2010 Sep; 21(13):892-6. PubMed ID: 21150487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Role of Endogenous Progesterone in Stroke Cerebroprotection Revealed by the Neural-Specific Deletion of Its Intracellular Receptors.
    Zhu X; Fréchou M; Liere P; Zhang S; Pianos A; Fernandez N; Denier C; Mattern C; Schumacher M; Guennoun R
    J Neurosci; 2017 Nov; 37(45):10998-11020. PubMed ID: 28986464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
    Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
    Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.